Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis

Yao‐Wen Chang(National Yang Ming Chiao Tung University), Ching‐Ping Tseng(Chang Gung University)

Oncotarget

October 29, 2015

10.18632/oncotarget.5811

Cited by 98

Related Papers

Disabled-2 is a negative immune regulator of lipopolysaccharide-stimulated Toll-like receptor 4 internalization and signaling

|Scientific Reports|2016|31

A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells

|Cell Reports Medicine|2023|18